| scholarly article | Q13442814 |
| P50 | author | Yao Liang Tang | Q75196587 |
| P2093 | author name string | Lan Zhang | |
| Muhammad Ashraf | |||
| Lijuan Chen | |||
| Gangjian Qin | |||
| Yingjie Wang | |||
| Chengxing Shen | |||
| Genshan Ma | |||
| Neal Weintraub | |||
| Yaohua Pan | |||
| P2860 | cites work | Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells | Q24300024 |
| The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors | Q24314957 | ||
| Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death | Q24595733 | ||
| Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
| MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells | Q33112708 | ||
| Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
| MicroRNA-214 and polycomb group proteins: a regulatory circuit controlling differentiation and cell fate decisions | Q33992454 | ||
| The microRNA cluster miR-106b~25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation | Q34169338 | ||
| ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium | Q35912379 | ||
| Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. | Q36211443 | ||
| A novel two-step procedure to expand cardiac Sca-1+ cells clonally. | Q36274962 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| MicroRNAs and cell cycle regulation | Q36929340 | ||
| Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice | Q37286681 | ||
| Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression | Q37372976 | ||
| MicroRNAs and cardiac pathology | Q37478072 | ||
| Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. | Q37691577 | ||
| Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'. | Q37841221 | ||
| Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
| Therapeutic potential of mesenchymal stem cell-derived microvesicles. | Q38031213 | ||
| Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction | Q42644713 | ||
| Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood | Q42647161 | ||
| A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. | Q45889472 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. | Q51961075 | ||
| Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. | Q54637483 | ||
| Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium | Q75196590 | ||
| Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
| Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector | Q81297170 | ||
| Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction | Q81884186 | ||
| Functional transfer of microRNA by exosomes | Q83289821 | ||
| Delayed postconditioning in the mouse heart in vivo | Q84851503 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 566-571 | |
| P577 | publication date | 2013-01-11 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury | |
| P478 | volume | 431 |
| Q90481195 | A New Era of Cardiac Cell Therapy: Opportunities and Challenges |
| Q38269076 | A New Gene Therapy Approach for Cardiovascular Disease by Non-coding RNAs Acting in the Nucleus |
| Q98159664 | Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases |
| Q98196677 | Application of exosomes as liquid biopsy in clinical diagnosis |
| Q60918030 | Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases |
| Q47137765 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. |
| Q49170207 | Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways |
| Q64922827 | C-Kit Cardiac Progenitor Cell Based Cell Sheet Improves Vascularization and Attenuates Cardiac Remodeling following Myocardial Infarction in Rats. |
| Q92152473 | Cardiac Extracellular Vesicles (EVs) Released in the Presence or Absence of Inflammatory Cues Support Angiogenesis in Different Manners |
| Q26770294 | Cardiac Extracellular Vesicles in Normal and Infarcted Heart |
| Q47763392 | Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair |
| Q57795698 | Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair |
| Q37482846 | Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. |
| Q54978584 | Cardiac progenitor cell‑derived exosomes promote H9C2 cell growth via Akt/mTOR activation. |
| Q34981722 | Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles |
| Q47763409 | Cardioprotective Effects of Exosomes and Their Potential Therapeutic Use. |
| Q92839749 | Cardioprotective effect of indirubin in experimentally induced myocardial infarction in wistar rats |
| Q38165939 | Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication |
| Q92090998 | Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles |
| Q50351165 | Characterization of extracellular vesicles derived from cardiac cells in an in vitro model of preconditioning. |
| Q48653724 | Circulating Exosomes in Cardiovascular Diseases |
| Q48100040 | Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke. |
| Q90207355 | Decellularized Extracellular Matrix Hydrogels as a Delivery Platform for MicroRNA and Extracellular Vesicle Therapeutics |
| Q92705008 | Derivation of Cell-Engineered Nanovesicles from Human Induced Pluripotent Stem Cells and Their Protective Effect on the Senescence of Dermal Fibroblasts |
| Q34043252 | Differential fates of biomolecules delivered to target cells via extracellular vesicles. |
| Q35786316 | Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction |
| Q28081849 | Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications |
| Q36657651 | Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps |
| Q57794663 | Evaluation of the cardioprotective potential of extracellular vesicles - a systematic review and meta-analysis |
| Q96132624 | Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts |
| Q88483632 | Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells |
| Q91027293 | Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health |
| Q38304096 | Exosome and its roles in cardiovascular diseases |
| Q47648689 | Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases |
| Q42872160 | Exosomes Explosion for Cardiac Resuscitation |
| Q30491901 | Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway |
| Q90048935 | Exosomes From Induced Pluripotent Stem Cell-Derived Cardiomyocytes Promote Autophagy for Myocardial Repair |
| Q39095686 | Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases |
| Q47446325 | Exosomes Mediate the Beneficial Effects of Exercise |
| Q26771909 | Exosomes and Their Therapeutic Potentials of Stem Cells |
| Q36816939 | Exosomes and exosomal miRNAs in cardiovascular protection and repair. |
| Q49942942 | Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases |
| Q49942907 | Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy |
| Q45974468 | Exosomes as agents of change in the cardiovascular system. |
| Q90168073 | Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways |
| Q50129823 | Exosomes derived from cardiac telocytes exert positive effects on endothelial cells |
| Q60953235 | Exosomes derived from cardiomyocytes promote cardiac fibrosis via myocyte-fibroblast cross-talk |
| Q58589843 | Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling |
| Q28081616 | Exosomes for Intramyocardial Intercellular Communication |
| Q51545509 | Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN. |
| Q37348712 | Exosomes from Human Synovial-Derived Mesenchymal Stem Cells Prevent Glucocorticoid-Induced Osteonecrosis of the Femoral Head in the Rat |
| Q88064808 | Exosomes from Suxiao Jiuxin pill-treated cardiac mesenchymal stem cells decrease H3K27 demethylase UTX expression in mouse cardiomyocytes in vitro |
| Q64074434 | Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress |
| Q39319239 | Exosomes in Cardiovascular Medicine. |
| Q90599368 | Exosomes in Coronary Artery Disease |
| Q28576809 | Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection |
| Q35748408 | Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. |
| Q59795422 | Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics |
| Q33657616 | Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology |
| Q38262125 | Exosomes: a potential key target in cardio-renal syndrome |
| Q39395324 | Exosomes: promising sacks for treating ischemic heart disease? |
| Q47164685 | Extracellular Vesicles Released by Oxidatively Injured or Intact C2C12 Myotubes Promote Distinct Responses Converging toward Myogenesis |
| Q89433754 | Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair |
| Q49196893 | Extracellular Vesicles in Cardiovascular Theranostics. |
| Q49183974 | Extracellular vesicles and cardiovascular disease therapy |
| Q99623721 | Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors |
| Q47741822 | Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics |
| Q38241188 | Extracellular vesicles as therapeutic tools in cardiovascular diseases |
| Q64287227 | Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes |
| Q33362561 | Extracellular vesicles in cardiovascular disease: are they Jedi or Sith? |
| Q39115035 | Extracellular vesicles in coronary artery disease. |
| Q46268171 | Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. |
| Q47304481 | Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair. |
| Q26767261 | Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles |
| Q91714289 | Freeze-Dried Extracellular Vesicles From Adipose-Derived Stem Cells Prevent Hypoxia-Induced Muscle Cell Injury |
| Q38460765 | Generation of cardiac progenitor cells through epicardial to mesenchymal transition. |
| Q38657334 | Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine |
| Q36882814 | Human cardiospheres as a source of multipotent stem and progenitor cells |
| Q35112471 | Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology |
| Q64325140 | Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain |
| Q58104007 | Immunomodulation by Exosomes in Myocardial Infarction |
| Q90348872 | Influence of microRNAs and exosomes in muscle health and diseases |
| Q39189306 | Insights into cell-free therapeutic approach: Role of stem cell "soup-ernatant". |
| Q91586770 | Interplay between Exosomes and Autophagy in Cardiovascular Diseases: Novel Promising Target for Diagnostic and Therapeutic Application |
| Q90720028 | Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration |
| Q49224369 | Isolation of Extracellular Vesicles from Stem Cells. |
| Q89841061 | M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway |
| Q92886229 | Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway |
| Q35170871 | MicroRNA profiling of pericardial fluid samples from patients with heart failure |
| Q88597093 | MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells |
| Q39154143 | MicroRNA-144 is a circulating effector of remote ischemic preconditioning |
| Q35661827 | MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death |
| Q38289373 | MicroRNAs in myocardial infarction |
| Q60056507 | Microvesicles and Exosomes in Local and Distant Communication with the Heart |
| Q38184460 | Microvesicles and exosomes for intracardiac communication |
| Q26770233 | Microvesicles and exosomes: new players in metabolic and cardiovascular disease |
| Q50050496 | Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration. |
| Q54943876 | Mitochondria in Cardiac Postconditioning. |
| Q41980044 | Mitochondrial pathways to cardiac recovery: TFAM. |
| Q61797275 | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
| Q36550793 | More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair |
| Q48247352 | Myocardial Regeneration via Progenitor Cell-Derived Exosomes |
| Q64950461 | Myocardial cell-to-cell communication via microRNAs. |
| Q39233936 | Nanotherapy for Duchenne muscular dystrophy |
| Q30361288 | New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia |
| Q38804978 | New strategies for improving stem cell therapy in ischemic heart disease |
| Q90667262 | Noncoding RNAs regulating cardiac muscle mass |
| Q34717025 | Pathologic function and therapeutic potential of exosomes in cardiovascular disease |
| Q35632958 | Perspectives on the Potential Therapeutic Uses of Vesicles. |
| Q43964974 | Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward. |
| Q64085300 | Potential role of exosomes in the pathophysiology, diagnosis, and treatment of hypoxic diseases |
| Q38794211 | Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation. |
| Q38249023 | Remote conditioning the heart overview: translatability and mechanism |
| Q64957921 | Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. |
| Q90307785 | Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease |
| Q38543812 | Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. |
| Q41193331 | Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90. |
| Q36267006 | Sorting it out: regulation of exosome loading |
| Q55071721 | Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. |
| Q90263716 | Stem Cell-Derived Exosomes Protect Astrocyte Cultures From in vitro Ischemia and Decrease Injury as Post-stroke Intravenous Therapy |
| Q38997197 | Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy |
| Q26771562 | Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges |
| Q58702281 | Stem cell-derived exosomes - an emerging tool for myocardial regeneration |
| Q28071466 | Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease |
| Q52654595 | Suxiao Jiuxin pill promotes exosome secretion from mouse cardiac mesenchymal stem cells in vitro. |
| Q92308023 | Systemic Infusion of Expanded CD133+ Cells and Expanded CD133+ Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI |
| Q52647641 | Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. |
| Q35531368 | Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells |
| Q57169628 | The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy |
| Q92535745 | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair |
| Q58771019 | The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases |
| Q28080565 | The Role of MicroRNAs in Cardiac Stem Cells |
| Q94465726 | The Small GTPases Rab27b Regulates Mitochondrial Fatty Acid Oxidative Metabolism of Cardiac Mesenchymal Stem Cells |
| Q35888026 | The biology of circulating microRNAs in cardiovascular disease. |
| Q37325686 | The potential of stem cells in the treatment of cardiovascular diseases |
| Q49942720 | Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases |
| Q52726173 | Therapeutic Potential of Engineered Extracellular Vesicles. |
| Q28068965 | Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases |
| Q59128840 | Therapeutic approaches for cardiac regeneration and repair |
| Q34041000 | Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience |
| Q57157827 | Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment |
| Q57056947 | Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis |
| Q38258936 | Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key. |
Search more.